NasdaqGS:LFSTHealthcare
LifeStance Health Group (LFST) Turned Profitable And Lifted Guidance, Is It Still Below Fair Value?
LifeStance Health Group (LFST) has drawn fresh investor attention after reporting second quarter net profitability, raising its 2026 revenue outlook, and pairing these updates with a completed US$97.19 million buyback along with a new US$100 million repurchase program.
See our latest analysis for LifeStance Health Group.
Those earnings and buyback headlines arrive after a strong run in LifeStance Health Group’s stock, with a 90 day share price return of 59.74% and a 1 year total shareholder...